What's New

FTD in the News

Aviado Bio CMO Discusses ASPIRE-FTD Clinical Trial with Neurology Live

In a recent interview with Neurology Live, Aviado Bio chief medical officer David Cooper, MD, discussed the…

Read More >
Picture of Nicole Petrie and the title AFTD Brand Influencer Discusses Commitment to Caring

AFTD Brand Influencer Discusses Commitment to Caring

AFTD Brand Influencer Nicole Petrie shared her family’s FTD journey with host Lisa Opie on the podcast…

Read More >
Text: Study Investigates Incidence Rates of FTD and Other Young-Onset Dementias in Italy Background: Two scientists looking over results on a PC screen

Study Investigates Incidence Rates of FTD and Other Young-Onset Dementias in Italy

A study published in the journal Diagnosis, Assessment & Disease Monitoring investigates the incidence of neurodegenerative young-onset…

Read More >

AFTD Grant Recipient Discusses Gene Therapy for FTD-GRN on Canadian TV

In an interview with the Canadian Broadcasting Corporation, Dr. Simon Ducharme of McGill University in Montreal discussed…

Read More >
Title: ASPIRE-FTD Phase 1/2 Clinical Opens First US Site at Ohio State University - Ohio State University campus in background.

ASPIRE-FTD Phase 1/2 Clinical Trial Opens First US Site at Ohio State University

Biopharmaceutical company AviadoBio announced on July 1 that its ASPIRE-FTD phase 1/2 clinical trial has opened its…

Read More >
Graphic; Care Partner Emphasizes the Benefits of Support from Others Who Understand FTD

Care Partner Emphasizes the Benefits of Support from Others Who Understand FTD

Navigating the FTD journey is much less daunting when you have support from others who have lived…

Read More >
Title: opinion column highlights racial disparities in dementia care and need for support. Image: doctor viewing MRI imaging on tablet.

Opinion Column Highlights Racial Disparities in Dementia Care and Need for Support

An opinion column published in the Los Angeles Daily News highlights healthcare-based racial disparities that often leave…

Read More >

A Conversation with Olga Uspenskaya, MD, PhD, of Prevail Therapeutics

Recently, Prevail Therapeutics presented interim results from their Phase 1/2 open-label clinical trial assessing the safety and…

Read More >
Graphic title: Passage Bio Receives Positive Feedback from FDA on Expanding Gene Therapy to C9orf72. Image: Person working in lab, looking through microscope

Passage Bio Receives Positive Feedback from FDA on Expanding Gene Therapy to C9orf72

Biopharmaceutical company Passage Bio announced on July 16 that it has received positive feedback from the U.S….

Read More >
Graphic: Research Explains the Role of Genetics in FTD, Discusses Avenues for Treatment.

Researcher Explains the Role of Genetics in FTD, Discusses Avenues for Treatment

In an article written for The Conversation, Fen-Biao Gao, PhD, professor and founding director of the FTD…

Read More >